HM Payson & Co’s NRC Health Common Stock NRC Stock Holding History

HM Payson & Co’s Portfolio NRC Stock Details NRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-37	Closed	-$2K	–	1115
2021 Q2	$2K	Buy	+37	New	+$1.76K	﹤0.01%	1005

Other funds holding NRC

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HM Payson & Co's NRC Position: Q3 2021 in Review

HM Payson & Co sold out of NRC Health Common Stock (NRC) in Q3 2021, closing a stake of 37 shares — an estimated $2K sold.

HM Payson & Co first reported a position in NRC in Q2 2021 and held it in 1 quarter. The position peaked at $2K in Q2 2021. 109 funds tracked by Wall St. Rank hold NRC as of Q3 2021.

HM Payson & Co reported no remaining NRC Health Common Stock position as of Q3 2021 after selling out during the quarter.
HM Payson & Co sold 37 NRC Health Common Stock shares in Q3 2021, an estimated $2K.
HM Payson & Co first reported a position in NRC Health Common Stock in Q2 2021 and held it in 1 quarter.
HM Payson & Co's NRC Health Common Stock position peaked at $2K in Q2 2021.
109 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q3 2021.

Based on HM Payson & Co's 13F filing for Q3 2021, filed 30 Nov 2021.